Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

152.89
+0.12000.08%
Post-market: 152.910.0213+0.01%18:11 EDT
Volume:4.46M
Turnover:691.87M
Market Cap:17.09B
PE:73.01
High:158.28
Open:153.49
Low:152.81
Close:152.77
52wk High:158.28
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:2.27
T/O Rate:4.37%
Dividend:0.28
Dividend Rate:0.18%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:2.36
PE(LYR):73.91

Loading ...

OverviewCompanyNewsFilings

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)

TIPRANKS
·
Sep 26

Revvity Inc. Stock Climbs 6.0%, Outperforms Peers

Dow Jones
·
Sep 25

Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test

MT Newswires Live
·
Sep 25

Revvity Shares Rise on Launch of Child Type 1 Diabetes Screening Test

MT Newswires Live
·
Sep 24

Revvity launches GSP T1D 3plex kit

TIPRANKS
·
Sep 24

Leerink Partners Adjusts Revvity Price Target to $160 From $145, Maintains Outperform Rating

MT Newswires Live
·
Sep 24

Revvity CFO Maxwell Krakowiak Sells 1,631 Shares Worth $235,525.43

Reuters
·
Sep 24

CFRA downgrades Revvity (RVTY) to a Hold

TIPRANKS
·
Sep 21

Weekly Winners | RVTY, CRWD Soar 15%; GNRC, COIN Up Over 10%; PANW, SNDK, FDS Rise More Than 9%

Tiger Newspress
·
Sep 20

S&P 500 Posts Slight Weekly Decline as Utilities Weigh

MT Newswires Live
·
Sep 19

Revvity SVP Global Operations Tajinder S. Vohra Sells 7,330 Shares Worth $1,032,650.40

Reuters
·
Sep 19

Revvity Inc. Stock Climbs 4.0%, Outperforms Peers

Dow Jones
·
Sep 17

Movement Alert｜REVVITY INC Rises 5.21% in Regular Trading, Acquisition of Human Cell Design Continues to Boost Market Sentiment

Market Focus
·
Sep 16

Revvity Inc. Stock Climbs 9.1%, Outperforms Peers

Dow Jones
·
Sep 16

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 16

Movement Alert｜REVVITY INC Rises 6.11% in Regular Trading, Acquisition of Human Cell Design Bolsters Metabolic Disease R&D Capabilities

Market Focus
·
Sep 15

Revvity Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Revvity Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120

MT Newswires Live
·
Sep 09
More